
A fibroblast growth factor receptor-blocking peptide is provided. In one embodiment, the peptide is a retro-peptide of the fibroblast growth factor receptor. The receptor-blocking peptide may be used in a therapeutic method for treatment of viral diseases, hypervascular diseases, and tumors.











